NCT03576508View on ClinicalTrials.gov

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Knee Osteoarthritis
Interventions
DRUG

CNTX-4975-05

1 mg (2mL) IA injection

DRUG

Qutenza

8% topical patch

DRUG

Lidocaine (without epinephrine)

15 mL IA injection of 2% lidocaine (without epinephrine)

Trial Locations (1)

33143

Well Pharma Medical Research, Corp, Miami

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY

NCT03576508 - A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis | Biotech Hunter | Biotech Hunter